GACM
UTHR icon

Green Arrow Capital Management’s United Therapeutics UTHR Stock Holding History

Green Arrow Capital Management’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-30,000
Closed -$3.86M – 172
2014
Q3 		$3.86M Buy
+30,000
New +$3.09M 0.32% 76

Other funds holding UTHR

ACM
Americafirst Capital Management Roseville, California $74M AUM 13.49% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return
AL
AJO LP Philadelphia, Pennsylvania $199M AUM 109.68% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Green Arrow Capital Management's UTHR Position: Q4 2014 in Review

Green Arrow Capital Management sold out of United Therapeutics (UTHR) in Q4 2014, closing a stake of 30,000 shares — an estimated $3.86M sold.

Green Arrow Capital Management first reported a position in UTHR in Q3 2014 and held it in 1 quarter. The position peaked at $3.86M in Q3 2014. 334 funds tracked by Wall St. Rank hold UTHR as of Q4 2014.

  • Green Arrow Capital Management reported no remaining United Therapeutics position as of Q4 2014 after selling out during the quarter.
  • Green Arrow Capital Management sold 30,000 United Therapeutics shares in Q4 2014, an estimated $3.86M.
  • Green Arrow Capital Management first reported a position in United Therapeutics in Q3 2014 and held it in 1 quarter.
  • Green Arrow Capital Management's United Therapeutics position peaked at $3.86M in Q3 2014.
  • 334 funds tracked by Wall St. Rank held United Therapeutics as of Q4 2014.

Based on Green Arrow Capital Management's 13F filing for Q4 2014, filed 17 Feb 2015.